RU2072854C1 - Method of acute respiratory disease treatment - Google Patents

Abstract

FIELD: medicine, otorhinolaryngology. SUBSTANCE: method involves administration of drugs in patient organism. Vilosen solution is dropped into nose choana of patient (by 5-7 drops, 5 times per a day, not above), dose for 24 h is 20 mg, for 3 days. EFFECT: decreased treatment period, excluding disease relapse.

Description

 The invention relates to medicine, namely to otorhinolaryngology, and can be used in ENT clinics in the treatment of acute respiratory diseases.

 A known method of treating acute respiratory diseases by prescribing a patient a complex of drugs with anti-inflammatory immunomodulatory effects.

 As a result of such treatment, the drug load on the body, often leading to allergic reactions, increases in the patient, against the background of an immunodeficiency state, the development of formidable complications (false croup, acute otitis media, pneumonia, craniocerebral complications, etc.) is possible. In addition, the treatment is long in time.

 The aim of the invention is to reduce the duration of treatment and the exclusion of relapses of acute respiratory diseases.

 This goal is achieved by the fact that according to the known method of treating acute respiratory diseases by administering drugs to the patient’s body, 5 7 drops of vilosen solution are instilled into the patient’s nasal passages, no more than 5 times a day, in a daily dose of 20 mg, for 3- x days.

 A comparative analysis of the proposed solution with the already known showed that for the first time for the treatment of acute respiratory diseases vilosen (non-protein low molecular weight thymus extract) was used, which meets the criterion of "novelty."

 The use of vilosen, compared with the use of anti-inflammatory drugs, can significantly reduce the treatment time for acute respiratory diseases and eliminates their relapse, which confirms the compliance of the claimed solution with the criterion of "inventive step".

 The proposed method is implemented as follows: in an ampoule with vilosen, immediately before use, add 2 ml of an isotonic solution of sodium chloride or boiled water. The resulting solution is injected into the nasal passages of the patient in an amount of 5 7 drops, not more than 5 times a day, in a daily dose of 20 mg. The course of treatment is not more than 3 days.

 The method is illustrated by clinical examples.

 PRI me R 1. Patient Krakhin I.V. Born in 1975 case history No. 2028 was admitted to the ENT department of the Regional Clinical Hospital No. 1 of Krasnoyarsk on 10.11.92 with a diagnosis of median cyst of the neck, acute respiratory disease. Upon receipt of a complaint of sneezing, headache, runny nose, sore throat, dry cough.

On examination: the abundance of transparent mucus in the nasal passages, the mucous membrane of the nose is hyperemic, the nasal concha is swollen, the mucous membrane of the oral cavity is hyperemic. The soft palate is movable. Tonsils are hypertrophied, behind the arches, lacunae are free. Body temperature 37.2 ^o C. On the midline of the neck palpable fluctuating formation, painless. There are no minigale signs.

 5 days before surgical treatment of the median cyst of the neck, acute respiratory disease was treated with vilosen solution by instillation in the nasal passages of 5 drops of the drug, 5 times a day. On the second day, mucous discharge from the nose disappeared, swelling of the nasal passages decreased, nasal breathing was restored, headaches did not bother. On the third day of applying vilosen: symptoms of acute respiratory disease are absent, satisfactory condition, the drug is canceled. Two days later, after discontinuation of the drug, an operation was performed to remove the median cyst of the neck. The postoperative period was uneventful. On the seventh day, the patient, in satisfactory condition, was discharged from the clinic.

 PRI me R 2. Patient Korolkov AN Born in 1970 medical history N 2840, was admitted to the Regional Clinical Hospital 1, Krasnoyarsk, in the ENT department 02/01/92 with a diagnosis of curvature of the nasal septum, acute respiratory disease. Upon receipt of a complaint of headaches, difficulty in nasal breathing, mucous membrane from the nose. On examination: swelling and hyperemia of the nasal mucosa, an abundance of mucus in the nasal passages, a curvature of the nasal septum to the right. The mucous membrane of the posterior pharyngeal hyperemic pharynx, through it, into the lower sections, transparent mucus flows. An acute respiratory disease was treated with a solution of vilosen, 7 drops of vilosen, 3 times a day. On the third day of using vilosen, there are no symptoms of acute respiratory disease, the condition is satisfactory, the drug is canceled. An operation was performed submucosal resection of the nasal septum. The postoperative period was uneventful. After 8 days, the patient was discharged from the hospital in satisfactory condition.

 Using the proposed method, 20 patients were treated. Full recovery occurred on average after 2.2 + 0.12 days. With further follow-up for 3 to 6 months, no relapse of acute respiratory disease was noted.

 The use of the prototype method, the use of a comprehensive medical arsenal was treated in 20 patients: recovery came to 7 9 days, when observed within a year after the disease, repeated relapses were noted in 27.2 ± 0.62% of patients.

Claims (1)

 A method of treating acute respiratory diseases by introducing drugs into the patient’s body, characterized in that 5 7 drops of vilosen solution are instilled into the patient’s nasal passages no more than 5 times a day in a daily dose of 20 mg for three days.